VERBESSERTE PEPTIDARZNEIMITTEL

Patent europeic · EP2709645 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2709645
Numer da la dumonda
EP12784971
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
17-05-2012
Publitgà
26-03-2014
Concedì
09-08-2023
Stritgà
24-12-2024
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 38/08 (2019.01)
A61K 31/35 (2006.01)
A61P 5/00 (2006.01)
C07K 7/06 (2006.01)
Prioritad
US 201161487638 P 18.05.2011
US 201161487636 P 18.05.2011
US 201161543725 P 05.10.2011
US 201161543721 P 05.10.2011
Dumonda PCT
PCT/US2012/038429 17.05.2012
Publicaziun PCT
WO2012/158962 22.11.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-12-2024

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.12.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.12.2024

  2. 19-06-2024

    Midada

    Published in Swissreg on 19.06.2024

  3. 09-08-2023

    Concedì

    Published in Swissreg on 09.08.2023

Partidas

Possessur

Eumederis Pharmaceuticals, Inc.

12707 High Bluff Drive, Suite 200, San Diego, CA 92130, US

Inventur

NESTOR, John J.

Encinitas CA 92024, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.